Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-11-30

Clinical Trial Update: Effect of Vitamin D3 Supplementation in Treatment of Irritable Bowel Syndrome [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating vitamin D3 supplementation for irritable bowel syndrome has completed, indicating preliminary safety and feasibility data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin D3 (Cholecalciferol)

Snippet

Sponsor: Ahvaz Jundishapur University of Medical Sciences | Conditions: Irritable Bowel Syndrome | Phase 1 | Status: COMPLETED